Actinium reports ATNM-400 cancer therapy data at AACR meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.07 -0.04 (3.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.11 | 52 Week High | $3.50 | |||
| Open | $1.08 | 52 Week Low | $0.86 | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $-7.61 | |||
| Volume | 100,093 | |||||
